Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.585
-0.125-2.19%
Volume:20.87M
Turnover:115.37M
Market Cap:104.34B
PE:36.77
High:5.630
Open:5.605
Low:5.440
Close:5.710
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.64
T/O Rate:0.11%
Dividend:0.12
Dividend Rate:2.15%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.74
PE(LYR):36.77
PS:2.65

Loading ...

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

Movement Alert|SBP GROUP Rises 3.14% in Regular Trading, Plans RMB 4.48 Billion Acquisition to Raise CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Movement Alert|SBP GROUP Rises 3.43% at Open, Plans RMB 4.48 Billion Acquisition to Boost CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Biopharma Giant's HK$4.48 Billion Stake Purchase Highlights Key Hong Kong Stock Market Announcements

Stock News
·
Sep 14

Crude Supply Shock Looms as Saudi Pipeline Outage Threatens 4% of Global Output

Stock News
·
Sep 14

Sino Biopharm Secures Deal to Up Stake in CT Tianqing

MT Newswires Live
·
Sep 11

Sino Biopharmaceutical - Sbp Group to Buy 5% Equity Interest in Ct Tianqing for Rmb4.48 Bln at 19X Ltm P/E

THOMSON REUTERS
·
Sep 11

Movement Alert|SBP GROUP Falls 3.19% in Regular Trading, Trading at HK$5.3

Market Focus
·
Sep 11

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Movement Alert|SBP GROUP Declines 3.08% in Regular Trading, Trading at 5.67 HKD

Market Focus
·
Sep 09

SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026

Stock News
·
Sep 08

Sino Biopharm Presents ERS 2026 Preclinical Data for Oral STAT6 Degrader Tqh5528

Reuters
·
Sep 08

Sino Biopharm CEO Tse Says AI, Internationalization Anchor Counter-Cyclical Growth Strategy

Reuters
·
Sep 08

Movement Alert|SBP GROUP Rises 3.02% in Regular Trading, TQC3721 Inhaler Phase I Clinical Data Presented at European Respiratory Society Annual Meeting

Market Focus
·
Sep 08

Hong Kong Stock Market Update | SBP GROUP (01177) Climbs Nearly 3% After TQC3721 Inhalation Powder Data Presented at ERS 2026

Stock News
·
Sep 08

SBP Group Unveils Positive Phase I Data for TQC3721 Dry-Powder Inhaler at ERS 2026

Bulletin Express
·
Sep 07

Sino Biopharma Reports Phase I Data Showing Tqc3721 Dry Powder Inhaler Boosts COPD Lung Function in Dose-Ranging Trial

Reuters
·
Sep 07

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 07